Searched for
EXTENDED RELEASE CAPSULES
Alembic Pharmaceuticals gets USFDA nod for generic hypertension treatment capsulesAlembic Pharmaceuticals Ltd has secured final approval from the USFDA for its generic Diltiazem Hydrochloride extended-release capsules. Th...- Alembic Pharma gets USFDA nod for generic hypertension treatment capsulesAlembic Pharmaceuticals has received USFDA final approval for its generic Diltiazem Hydrochloride extended-release capsules in strengths of...
- Zydus Lifesciences gets USFDA nod for generic medicationZydus Lifesciences has received approval from the USFDA to market Amantadine extended-release capsules (68.5 mg) and tentative approval for...
- Sun Pharma recalls around 55k bottles of generic medication in USSun Pharma is recalling approximately 55,000 bottles of a generic medication used to treat bowel disease in the US market. The recall is du...
- Granules gets USFDA's nod for Amphetamine capsulesAmphetamine is bioequivalent to the reference listed drug product (RLD), Adderall XR extended-release capsules of Takeda Pharmaceuticals. T...
- Alembic Pharma jumps over 6% on getting approval from USFDA for Mesalamine extended-release capsules“The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Apriso Extended-Release Capsules, 0.375 g, of ...
- Alembic Pharma receives final approval from USFDA for generic Mesalamine extended-release capsulesThe approved drug is therapeutically equivalent to Salix Pharmaceuticals Inc's reference listed drug (RLD), Apriso extended-release capsule...
- Sun Pharma gets USFDA nod for generic drug Mesalamine extended release capsulesThe company has received approval from the US Food and Drug Administration (USFDA) for the product, a generic version of Pentasa extended r...
- Glenmark gets USFDA nod for generic high blood pressure drugDrug firm Glenmark Pharmaceuticals on Tuesday said it has received approval from the US health regulator for its generic Diltiazem Hydrochl...
- Glenmark Pharma gets USFDA nod for seizure treatment drugGlenmark Pharmaceuticals Ltd has received final approval from the United States Food and Drug Administration (USFDA) for Topiramate extende...
- Granules India gets USFDA nod for overactive bladder treatment capsule"The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application filed by Granules Pharmaceuticals, Inc, a wh...
- Glenmark gets USFDA approval for Rythmol SR genericPropafenone Hydrochloride extended-release capsules is generic version of GlaxoSmithKline, LLC's Rythmol Capsules.
- Glenmark gets USFDA nod for generic anti-inflammatory drugThe approval granted to Glenmark Pharmaceuticals Inc by the USFDA is for Indomethacin extended-release capsules of 75 mg strength, the comp...
- Cadila inks pact with Supernus Pharma to settle patent issueCadila Healthcare have finalised an agreement with Supernus Pharmaceuticals Inc to settle all outstanding patent litigation.
- Aurobindo recalls 47,000 bottles of antidepressant capsules in USThe US arm of Aurobindo Pharma is recalling 47,040 bottles of Venlafaxine Hydrochloride extended release capsules, manufactured by the Hyde...
- Lupin gets USFDA nod to market Potassium Chloride capsulesLupin has received final approval from the US health regulator to market Potassium Chloride extended release capsules, used to treat potass...
- Sun Pharma gets USFDA approval for acne drugSun Pharmaceutical Industries today said it has received approval from the US health regulator for its new drug application for acne treatm...
- Orchid Chemicals gets USFDA nod for two generic drugsThe nod was for generic Rivastigmine capsules and Felodipine extended release tablets aimed at treating mild to moderate dementia and hyper...
- Sun Pharma gets USFDA nod for generic cardiac capsulesDiltiazem HCl extended-release capsules are indicated for the treatment of hypertension and for the management of angina.
- Aurobindo Pharma gets USFDA nod for anti-depression capsulesThe product has a global market size of about USD 2.4 billion for the twelve months ending September 2010 according to IMS study group.
Load More
